BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Iran warns its ready to open new front in Yemen, close Bab al-Mandab Strait with Houthis - 215 Preposterous Cosplay Ensembles That Will Blow You Away
- 3Poll: Most are satisfied with their health insurance, but a quarter report denials or delays
- 4Step by step instructions to Recognize the Distinction Between Lab Jewels and Precious stone Simulants
- 5Apollo's impatient old-timers are rooting for NASA's return to the moon with Artemis II launch
- Dozens killed as Angola flood death toll rises
- People Are Sharing The One Picture They Can't See Without Laughing, And It's The Comedy Spiral You Need Today
- Share your pick for the tree that you love for its novel magnificence!
- Nigeria’s return to Windsor castle signals new era in UK economic partnership
- Ukrainian Army Converts E38 BMW 7-Series Into Multiple Rocket Launch Platform
- Cocaine, caffeine, painkillers consumed by sharks in Bahamas, study finds
- Modern surgery began with saws and iron hands – how amputation transformed the body in the Renaissance
- How Deforestation Is Reshaping Mosquito-Human Contact
- ABC News' Sam Champion opens up about recent health scare
